Slover Peter T has filed 3 insider transactions across 1 company since May 2024.
Most recent transaction: a grant/award of 192000 shares of Contineum Therapeutics, Inc. ($CTNM) on January 30, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 30, 2026 | Contineum Therapeutics, Inc. | $CTNM | Slover Peter T | Chief Financial Officer | A | Stock Option (right to buy) | 192000 | $0.00 | 192,000.0000 | 28,115,548 | 9999.99% | 0.68% |
| Jan. 31, 2025 | Contineum Therapeutics, Inc. | $CTNM | Slover Peter T | Chief Financial Officer | A | Stock Option (right to buy) | 110000 | $0.00 | 110,000.0000 | 19,352,859 | 9999.99% | 0.57% |
| May 24, 2024 | Contineum Therapeutics, Inc. | $CTNM | Slover Peter T | Chief Financial Officer | A | Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 2,308,972 | 9999.99% | 4.33% |